These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

103 related articles for article (PubMed ID: 18605410)

  • 1. Tumor-specific humoral antibodies against plasma cell tumors in immunized BALB/c mice.
    Lespinats G
    J Natl Cancer Inst; 1970 Nov; 45(5):845-51. PubMed ID: 18605410
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Regulation of immune responses against the syngeneic ADJ-PC-5 plasmacytoma in BALB/c mice. I. Analysis of immune parameters involved.
    Cihak J; Ziegler HW; Kölsch E
    Immunology; 1981 May; 43(1):133-43. PubMed ID: 6265346
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Myeloma-specific antibodies: studies of their properties and their relationship to tumor immunity.
    Frikke MJ; Bridges SH; Lynch RG
    J Immunol; 1977 Jun; 118(6):2206-12. PubMed ID: 864258
    [No Abstract]   [Full Text] [Related]  

  • 4. Selection of anti-cancer antibodies from combinatorial libraries by whole-cell panning and stringent subtraction with human blood cells.
    Siva AC; Kirkland RE; Lin B; Maruyama T; McWhirter J; Yantiri-Wernimont F; Bowdish KS; Xin H
    J Immunol Methods; 2008 Jan; 330(1-2):109-19. PubMed ID: 18096183
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Antibody against the antigen receptor of a plasmacytoma prolongs survival of mice bearing the tumor.
    Beatty PG; Kim BS; Rowley DA; Coppleson LW
    J Immunol; 1976 May; 116(5):1391-6. PubMed ID: 1270800
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Protection against MOPC-315 plasmacytoma by immunization with C-type particle preparations.
    Kleinman R; Dray S
    Cancer Res; 1978 Jan; 38(1):223-5. PubMed ID: 201375
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Defining the heterogeneity of anti-tumor antibody responses.
    Segal GP; Klinman NR
    J Immunol; 1976 Jun; 116(6):1539-46. PubMed ID: 58038
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Immunization with mimotopes prevents growth of carcinoembryonic antigen positive tumors in BALB/c mice.
    Brämswig KH; Knittelfelder R; Gruber S; Untersmayr E; Riemer AB; Szalai K; Horvat R; Kammerer R; Zimmermann W; Zielinski CC; Scheiner O; Jensen-Jarolim E
    Clin Cancer Res; 2007 Nov; 13(21):6501-8. PubMed ID: 17975163
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Isolation of a specific plasmacytoma tumor antigen, reactive both in humoral and cell mediated immunity.
    Kolb JP; Lespinats G; Poupon MF
    Ann Immunol (Paris); 1974; 125 C(5):835-45. PubMed ID: 4142374
    [No Abstract]   [Full Text] [Related]  

  • 10. Inhibitory effect of endotoxin on the growth of plasma cell tumor.
    Bober LA; Kranepool MJ; Hollander VP
    Cancer Res; 1976 Mar; 36(3):927-9. PubMed ID: 766964
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Two tumor-associated membrane antigens defined by monoclonal antibodies in a transplantable sarcoma induced by Rous sarcoma virus in rat.
    Alexandrov I; Toshkova R; Alexandrov M; Dimitrov T; Sotirov N
    Neoplasma; 1996; 43(4):275-82. PubMed ID: 8931754
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Primary humoral immune response against tumor membrane antigens and foreign antigens by plasma cell tumor bearer mice.
    Bertini M; Marinone C; Giovarelli M; Comoglio PM
    G Batteriol Virol Immunol; 1977; 70(7-12):144-56. PubMed ID: 615743
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The specific blocking of humoral immune cytolysis mediated by anti-tumor antibodies degraded by lysosomal enzymes of tumor origin.
    Keisari Y; Witz IP
    Eur J Immunol; 1975 Nov; 5(11):790-5. PubMed ID: 1052439
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Passive immunity to murine plasmacytoma by rabbit antiidiotypic antibody to myeloma protein.
    Chen Y; Yakulis V; Heller P
    Proc Soc Exp Biol Med; 1976 Jan; 151(1):121-5. PubMed ID: 1250837
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Inhibition of murine plasmocytoma tumours with antibody activity by their respective specific antigens.
    Paraf A; Guérin-Marchand C; Aubry J; Dubert JM
    Ann Immunol (Paris); 1975; 126C(4):411-21. PubMed ID: 55094
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Immunogenicity of the Gardner lymphosarcoma for the mice of the strain C3H (H-2k). I. The effect of the 60Co-irradiation of recipients and of the interval between the immunization and transplantation of the tumor on the antitumor resistance of immunized mice.
    Motycka K; Bostík J; Danĕk PF; Chudomel V
    Neoplasma; 1986; 33(2):167-75. PubMed ID: 3754936
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Effect of the cell dose on the development of 2 transplantable tumors in a syngeneic host].
    Pugliese A; Choc O
    G Batteriol Virol Immunol; 1976; 69(1-6):122-31. PubMed ID: 15919
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Idiotype-specific transplantation resistance to MOPC-315: abrogation by post-immunization thymectomy.
    Daley MJ; Gebel HM; Lynch RG
    J Immunol; 1978 May; 120(5):1620-4. PubMed ID: 77876
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Development of highly sensitive Bicistronic vector based non-radioactive antigen-specific cytotoxicity assay.
    Gupta P; Tayal R; Durgapal H; Rath S; Acharya SK; Panda SK
    J Immunol Methods; 2009 Sep; 349(1-2):28-37. PubMed ID: 19682994
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Immunogenicity of multi-epitopes gene of major outer membrane protein of Chlamydia trachomatis].
    Zhu SL; Shi ZH; Li WS; Chen J; Zhang LF
    Zhonghua Yu Fang Yi Xue Za Zhi; 2009 Mar; 43(3):232-6. PubMed ID: 19534931
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.